CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 35 enrolled
Drug / intervention
Potassium chloride powder +3 moredrug
Likely dose
Potassium chloride powder 250 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01682837
NCT01682837Phase 2Completed
CompareCT.gov

Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension

University of Texas Southwestern Medical Center·interventional·Posted Sep 11, 2012·Updated Apr 28, 2017

In Brief

A Phase 2 clinical trial evaluating Potassium chloride powder, Potassium citrate powder, and 2 other interventions for Hypertension. Completed, enrolled 35 participants across 1 site.

Detailed Summary

Liquid potassium-magnesium citrate (KMgCit) as a pharmaceutical formulation will lower blood pressure among patients with pre- or Stage I hypertension on their customary diet.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 11, 2012
Enrollment StartOct 1, 2012
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 13.8 years ago

Interventions

Potassium chloride powderdrug

1 sachet mixed with 250 ml water (providing 20 meq K) given at breakfast and again dinner, for a total of 40 meq K/day, for 4 weeks

Potassium citrate powderdrug

1 sachet mixed with 250 ml water (providing 20 meq K) given at breakfast and dinner, for a total of 40 meq K/day, for 4 weeks

Potassium magnesium citrate powderdrug

1 sachet mixed with 250 ml water (providing 20 meq K) given at breakfast and dinner, for a total of 40 meq K/day, for 4 weeks

Placebodrug

1 sachet mixed with 250 ml water given at breakfast and dinner, for a total of 2 sachets/day, for 4 weeks